Search
for
Sort by
Research 511–540 of 690
- Maximizing surgical outcomes with gender affirming hormone therapy in gender affirmation surgery
- Ovine placental steroid synthesis and metabolism in late gestation†
- The gut‐microbiota‐brain axis: Focus on gut steroids
- Androgens in cervical cancer: Their role in epidemiology and biology
- Extracellular Vesicles as Surrogates for Drug Metabolism and Clearance: Promise vs. Reality
- A Review of the Most Common Dermatologic Conditions and their Debilitating Psychosocial Impacts
- Evolution, classification, structure, and functional diversification of steroid 5α-reductase family in eukaryotes
- Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome
- Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome
- Polycystic Ovary Syndrome and the Potential for Nanomaterial-Based Drug Delivery in Therapy of This Disease
- Simultaneous Determination of Selected Steroids with Neuroactive Effects in Human Serum by Ultrahigh-Performance Liquid Chromatography–Tandem Mass Spectrometry
- PCOS in Adolescents—Ongoing Riddles in Diagnosis and Treatment
- Drug interactions between common dermatological medications and the oral anti-COVID-19 agents nirmatrelvir-ritonavir and molnupiravir
- Nutritional Disorders of the Hair and Their Management
- Pubertal hormones increase hippocampal expression of α4βδ GABAA receptors
- Comparative advantage and efficacy of natural products for polycystic ovary syndrome
- Challenges in treatment of patients with non-classic congenital adrenal hyperplasia
- The connection of 5-alpha reductase inhibitors to the development of depression
- The emerging roles of N6-methyladenosine (m6A) deregulation in polycystic ovary syndrome
- Immunological and Metabolic Causes of Infertility in Polycystic Ovary Syndrome
- Hormonal Therapies in Cosmetic Dermatology: Mechanisms, Clinical Applications, and Future Perspectives
- Pathophysiology and Nutritional Approaches in Polycystic Ovary Syndrome (PCOS): A Comprehensive Review
- Oral contraceptive pill (OCP) treatment alters the gene expression of intercellular adhesion molecule-1 (ICAM-1), tumor necrosis factor-α (TNF-α), monocyte chemoattractant protein-1 (MCP-1) and plasminogen activator inhibitor-1 (PAI-1) in polycystic ovary syndrome (PCOS) women compared to drug-naive PCOS women
- Hair-Based Assessment of Sex Steroid Hormones in Patients with Anorexia Nervosa
- A Randomized Cohort Study: Is It Worth the Time to Receive Antiandrogenic Pretreatment Before Ovulation Induction for Women With Polycystic Ovary Syndrome?
- Frontal Fibrosing Alopecia and Reproductive Health: Assessing the Role of Sex Hormones in Disease Development
- Skin Androgen-Related Disorders: Hormonal Treatment
- Hyperandrogenic Symptoms Are a Persistent Suffering in Midlife Women with PCOS; a Prospective Cohort Study in Sweden
- Androgens/Androgen Receptor in the Management of Skin Diseases
- Evaluation of changes in meibomian glands in polycystic ovary syndrome by noncontact infrared meibography